Luisa Salter-Cid joins long­time Bris­tol My­ers col­lab­o­ra­tor Paul Bion­di at Flag­ship's new drug brew­ery

Paul Bion­di is gain­ing a fa­mil­iar re­search chief at his cor­ner of Flag­ship Pi­o­neer­ing.

The am­bi­tious VC — fa­mous for bold plat­form plays such as Mod­er­na — said Luisa Salter-Cid is join­ing Pi­o­neer­ing Med­i­cines as CSO, with the man­date of lever­ag­ing the plat­forms of var­i­ous Flag­ship port­fo­lio com­pa­nies to con­ceive new treat­ments.

The two had crossed paths at Bris­tol My­ers Squibb, where Bion­di brought in a se­ries of new drugs through­out his pro­lif­ic busi­ness de­vel­op­ment stretch while Salter-Cid worked her way up the lad­der to be­come head of im­munol­o­gy, small mol­e­cule im­muno-on­col­o­gy and ge­nomics dis­cov­ery.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER